Originally published on sanofi.com. Sanofi is No. 28 on the 2020 DiversityInc Top 50 Companies for Diversity list. New Phase 2 study assesses the potential for refined antigen formulation to achieve an optimal immune response, including in older adults If results are positive, Phase 3 study to start in Q2…
Tag: biomedical
Tweets
The @US_FDA announced that women seeking #abortionpills will no longer require an in-person visit to the doctor's o… https://t.co/n03CTNDSdN
In another historic first for President Biden's administration, foreign policy and national security expert… https://t.co/gk7oqw0kLN
#LinkedIn has announced new “#stayathome” titles for #parents. Beyond greater #representation of all the varied typ… https://t.co/QZPBLwT42N